HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

[A case of complete regression of liver metastases by treatment with Futraful supposition].

Abstract
The patient was a 57-year-old man abnormalities indicated in examinations by X-ray and ultrasonography in February, 1991. X-ray and endoscopic examination revealed a Borrmann type 3 carcinoma in the posterior wall and lesser curvature of the upper body of the stomach. The liver was swollen to 3 fingerbreadths on the right mid-clavicular line. Multiple liver metastases were revealed by computed tomography (CT). Proximal gastrectomy was done. From March 24, 1991, a Futraful suppository (1,500 mg/day) was given daily. After 4 months, CT showed the reduction and partial disappearance of the low-density areas of the liver. After 2 years and 7 months, CT showed very small low-density areas, which completely disappeared by April, 1998. The patient has had a good quality of life. According to the General Rules for Gastric Cancer Study, the patient belongs to the class of complete response.
AuthorsM Noji, T Bandoh, T Isoyama, S Nagaoka, M Fujiwara, T Takemura
JournalGan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 27 Issue 2 Pg. 285-8 (Feb 2000) ISSN: 0385-0684 [Print] JAPAN
PMID10700902 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Antimetabolites, Antineoplastic
  • Suppositories
  • Tegafur
Topics
  • Adenocarcinoma (drug therapy, secondary)
  • Antimetabolites, Antineoplastic (administration & dosage)
  • Humans
  • Liver Neoplasms (secondary)
  • Male
  • Middle Aged
  • Remission Induction
  • Stomach Neoplasms (drug therapy, pathology)
  • Suppositories
  • Tegafur (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: